Companies Developing Non-invasive and Wearable Glucose Monitoring Devices That Can Report Test Data in Real Time to Physicians and Clinical Laboratories

Oct 17, 2014 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Management & Operations

Goal is to shift glucose testing away from medical laboratories and make it easier for diabetics to do their own testing, while capturing glucose test results in patient records

Because of the tremendous volume of glucose tests performed daily throughout the world, many companies are developing non-invasive methods for glucose testing. Their goal is a patient-friendly technology that does not require a needle stick or venipuncture and may even eliminate the need to send specimens to a medical laboratory.

What is intriguing about these initiatives is that, in their final form, they may create a flow of useful diagnostic data reported to clinical laboratories in real time. This would create the opportunity for pathologists and lab scientists to consult with the patients’ physicians, while archiving this test result data in the laboratory information system (LIS).

These glucose monitoring methods would also ensure that a complete longitudinal record of patient tests results is available to all the physicians practicing in an accountable care organization (ACO), medical home, or hospital.  (more…)

New York Genome Center Opens New Gene Sequencing and Bioinformatics Facility in Downtown Manhattan

Nov 11, 2013 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology

The Center brings together scientists from around the city to translate promising research into medical innovations to treat, prevent and manage disease

Gene sequencing is going big time in the Big Apple. Last month the New York Genome Center (NYGC) moved into a state-of-the-art, 170,000-square-foot genome sequencing and biometrics research building. New York City is putting down its marker to claim a leading role in advancing genetic knowledge.

What makes this development notable for the clinical laboratory industry and the anatomic pathology profession is the fact that cities across the nation are investing substantial amounts of capital to create their own genetic and biotech research and development hubs. Their common objective is to bring together all the expertise, financial support, and business acumen needed to create a job-creating critical mass in the fields of biotech and genetic medicine. (more…)

;